MYLAN 5050 MYLAN 5050 Pill - yellow capsule/oblong, 16mm
Pill with imprint MYLAN 5050 MYLAN 5050 is Yellow, Capsule/Oblong and has been identified as Temazepam 30 mg. It is supplied by Mylan Pharmaceuticals Inc.
Temazepam is used in the treatment of Insomnia and belongs to the drug class benzodiazepines. Not for use in pregnancy. Temazepam 30 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for MYLAN 5050 MYLAN 5050



Temazepam
- Imprint
- MYLAN 5050 MYLAN 5050
- Strength
- 30 mg
- Color
- Yellow
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Benzodiazepines
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
silicon dioxide,
magnesium stearate,
microcrystalline cellulose,
cellulose powdered,
sodium lauryl sulfate,
FD&C Yellow No. 6,
titanium dioxide,
D&C Yellow No. 10,
ferrosoferric oxide,
FD&C Blue No. 1,
FD&C Blue No. 2,
FD&C Red No. 40,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00378-5050 (Discontinued) | Mylan Pharmaceuticals Inc. |
51079-0419 (Discontinued) | UDL Laboratories Inc. |
33261-0102 | Aidarex Pharmacuticals, LLC (repackager) |
49999-0346 | Lake Erie Medical and Surgical Supply (repackager) |
54569-1726 (Discontinued) | A-S Medication Solutions, LLC (repackager) |
66267-0321 | Nucare Pharmaceuticals Inc. (repackager) |
67544-0127 | Prepak Systems Inc. (repackager) |
More about temazepam
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (448)
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: benzodiazepines
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.